29 articles from this collection:
PME December 2025
2 COMMUNIQUE 2026
3 Comment
4 PME
5 Contents
6 News
Roche and Ascidian agree to $1.8bn neurological disease partnership
7 News
8 News
Researchers identify new major cause of inflammatory bowel disease
9 News
10 DARWIN'S MEDICINE - The Goldilocks zone
The evolutionary lessons for Bayer’s management restructure
11 MIKE DIXON - The social media imperative
Collecting the right data in the right way for the right reasons
12 HEALTHCARE - Unlocking the full potential of healthcare company partnerships
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
15 HEALTHCARE: How personalised healthcare will shape pharma’s role and reputation by 2030
14-17 ALLERGY AND AUTOIMMUNE DISEASES - Allergy and autoimmune diseases
Across almost every sector, brands are multiplying their investment in creativity
18-19 GLOBAL BREAST CANCER REPORT - OAdvanced Breast Cancer – a landmark Global Decade Report
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
19 TL AVALERE HEALTH - Launch differently: how unforgettable brands break through
21 TL INIZIO - How smart scaling and strategic implementation of AI are transforming life sciences
Picking your omnichannel direction requires a disciplined, scientific approach
22-23 ONCOLOGY - How next-generation diagnostics and precision therapies are redefining the prostate cancer landscape
24 TL SYNEOS HEALTH - Predicting the future of health equity in the pharmaceutical industry
25 TL SYNEOS HEALTH - Scaling AI in healthcare communications: from pilots to living systems
26-31 PMEA 2025: a celebration of excellence in pharmaceutical marketing
32 TL JPA HEALTH - Clicks vs credibility: how social media underscores patient understanding
33 TL VEEVA - The next era in life sciences: agentic AI and other innovations transforming HCP engagement
34-35 PRODUCT READINESS - Is your healthcare product market-ready?
‘Patient engagement is both a process and a behaviour throughout the drug life cycle’
36 Appointments
37 Appointments
38 RARE DISEASES - The BioIndustry Association calls for a new rare disease treatment pathway
39 SAMEDAN
40 EHP AWARDS 2026
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services